Discover What’s Next for Infant Nutrition
The 3rd Novel Ingredients for Infant Formula Summit 2026 arrives at a pivotal moment for infant nutrition.
Following high-profile contamination recalls, the implementation of Operation Stork Speed, and growing consumer scrutiny around ingredient safety, expectations for transparency, compliance, and scientific rigor have never been higher.
As companies pursue bioactives that more closely reflect the nutritional and immunological benefits of human breast milk, the industry must balance innovation with unequivocal safety, clear regulatory strategy, and commercially viable scale-up.
Bringing together ingredient providers, formula manufacturers, food tech innovators, regulatory authorities, and academic experts, the summit is purpose-built to accelerate novel ingredients from discovery through approval and market entry.
With focused discussions on global submission pathways, evidence expectations, formulation and stability challenges, and the advancement of HMOs, lactoferrin, osteopontin, lysozyme, and specialty lipids, this meeting equips leaders with the clarity and collaboration needed to responsibly shape the future of infant nutrition.
What's New for 2026?
Innovative Food Tech’s Presenting
2026 brings together innovative Food Tech executives from Numi, Totality Biosciences, Primogene and more to explore exciting new technologies in producing and scaling a wider range of human milk-like ingredients
Unique Focus on Path to Market
Exploring how ingredient decision‑making truly happens, from evidence thresholds to commercial viability, with expert leadership from Novonesis, offering clear insight into what advances novel ingredients from early screening to full adoption
Collaborative Deep-Dive on Regulatory Submissions
Featuring breakthrough insights on aligning global safety expectations and accelerating approval pathways for novel infant formula ingredients, spotlighting evidence design, strategic dossier preparation, and region‑specific regulatory navigation from industry leaders across early‑life nutrition
Explore the Full Event Guide
- Discover 70+ R&D, regulatory, and commercial leaders from ingredient providers, infant formula manufacturers, foodtech innovators, academia, and government
- Preview 3 days of exclusive insights across novel bioactive discovery, clinical validation, regulatory approval pathways, formulation challenges
- Explore dedicated deep-dive workshops navigating evidence expectations in infant formulation, approval pathways & more
- Share easily with your team to assess and mobilize interest
Attending Companies Include
Explore the Agenda
Discover forward-looking sessions on novel bioactives, clinical validation strategies, global regulatory pathways, formulation challenges, and commercial scale-up shaping the future of infant nutrition
Partner With Us
Connect with senior R&D, regulatory, and commercial leaders across ingredient providers, formula manufacturers, and foodtech companies seeking innovative, evidence-backed solutions to accelerate safe market entry
Join Industry Leaders
Network with decision-makers and innovators defining the next generation of clinically validated regulatory-ready ingredients designed to narrow the gap between formula and human breast milk